Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
yun nan zhi wu zhi
None
Encyclopedia of Biodiversity
The 7-volume Encyclopedia of Biodiversity, Second Edition maintains the reputation of the highly regarded original, presenting the most current information available in this globally crucial area of research and study. It brings together the dimensions of biodiversity and examines both the services it provides and the measures to protect it. Major themes of the work include the evolution of biodiversity, systems for classifying and defining biodiversity, ecological patterns and theories of biodiversity, and an assessment of contemporary patterns and trends in biodiversity. The science of biodiversity has become the science of our future. It is an interdisciplinary field spanning areas of bot...
The Plants of China
A unique addition to the botanical literature, this book presents the flora of China in its astonishing diversity.
Annual Report
None
The outstanding universal value and conservation of Hubei Shennongjia
This book owes a great deal to the outstanding universal value of the natural heritage of Hubei Shennongjia, which offers an outstanding example of the ongoing ecological processes occurring in the development of intact subtropical mixed broad-leaved evergreen and deciduous forests in the northern hemisphere. The book demonstrates the value from the typical example of mountain altitudinal biological zones in the Oriental Deciduous Forest Biogeographical Province, and the vital origin location for global temperate flora, harboring the highest concentration of global temperate genera. Moreover, the heritage value in exceptional biodiversity and key habitat for numerous relic, rare, endangered, endemic, and type specimen species are presented. The richness of deciduous woody species in Shennongjia is the highest in the world.
Biomarkers and Immunotherapy of Hepatic-Biliary-Pancreatic Cancers
Hepatic-biliary-pancreatic cancers, mainly including hepatocellular carcinoma, cholangiocarcinoma, gallbladder cancer, are highly aggressive malignancies with few treatment options and poor prognoses. Effects of the traditional systemic treatments such as chemotherapy and radiotherapy, are quite limited to hepatic-biliary-pancreatic cancers. For the patients who suffer from hepatic-biliary-pancreatic cancer and lose the opportunity of radical surgery, few targeted drugs are available. Even for the drugs in clinical trial, potential drug targets and prognostic biomarkers for hepatic-biliary-pancreatic cancer are less studied compared to other common cancers such as lung cancer. Prognostic biomarker study is the initiation to explore new drug targets and revelation of the underlying mechanisms of tumor progression.
